查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598471

局部傷口護理藥物市場：按產品、應用和最終用戶 - 全球預測 2025-2030

Topical Wound Agents Market by Product (Cream, Gel, Spray), Application (Acute Wound, Chronic Wound), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，局部傷口護理市場價值為26.1億美元，預計到2024年將達到28.9億美元，複合年成長率為10.99%，預計到2030年將達到54.2億美元。

局部傷口護理治療是用於治療和處理各種類型傷口的專門配方，包括擦傷、撕裂、燒燙傷和潰瘍。這些範圍包括促進癒合、預防感染、促進皮膚修復、解決急性和慢性傷口護理需求。對此類藥物的需求源於與糖尿病相關的足部潰瘍的增加、全球人口老化更容易受到意外傷害以及外科手術的普及。主要應用在醫院、居家醫療和傷口診所，產品有霜劑、軟膏劑、凝膠劑等形式。最終用途的範圍包括醫療保健專業人員、相關人員和患者本身，強調廣泛的相關人員參與。

主要市場統計
基準年[2023] 26.1億美元
預測年份 [2024] 28.9億美元
預測年份 [2030] 54.2億美元
複合年成長率（%） 10.99%

根據市場洞察，智慧敷料和生物活性傷口劑的整合等技術進步在市場成長中發揮重要作用。推動這一成長的因素包括醫療保健支出增加、對先進創傷護理意識的提高以及整容手術的增加。然而，先進的傷口護理產品也存在一些挑戰，包括高成本、嚴格的監管核准以及不同的地區報銷政策。隨著醫療基礎設施不斷擴大和醫療需求顯著未被滿足，新興市場蘊藏商機。您還可以利用數位健康解決方案進行遠距傷口評估，從而融入遠端醫療的趨勢。對公司的建議包括策略性地關注多功能創傷護理產品的研發、促進與醫療保健提供者的合作以及優先考慮高成長地區的市場滲透策略。

創新和研究將集中於開發生物分解性、非黏性傷口敷料，並投資奈米粒子等藥物傳輸系統，以提高創傷治療的效率。在探索市場的本質時，值得注意的是，這是一個競爭激烈、創新主導的市場，個人化醫療仍然存在巨大的機會。能夠快速適應這些動態、持續投資創新並回應患者和提供者需求的公司可能仍然能夠發展並保持競爭力。

市場動態：快速發展的局部傷口護理市場的關鍵市場洞察

供需的動態交互作用正在改變局部傷口護理市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球急性和慢性傷口增加
    • 交通事故和傷害增加
    • 政府措施提高對傷口感染的認知
  • 市場限制因素
    • 對抗生素的擔憂
  • 市場機會
    • 不斷推出技術先進的產品
    • 智慧創傷護理與數位健康的出現
  • 市場挑戰
    • 嚴格的核准流程

波特五力：開拓局部傷口護理市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解局部傷口護理藥物市場的外在影響

外部宏觀環境因素在塑造局部傷口護理藥物市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解局部傷口護理藥物市場的競爭狀況

局部傷口護理藥物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣局部傷口護理市場供應商的績效評估

FPNV定位矩陣是評估局部傷口護理市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和局部，以規劃傷口護理藥物市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對局部傷口護理藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球急性和慢性傷口的發生率增加
      • 交通事故和創傷事件增加
      • 政府加強提高對傷口感染的認知
    • 抑制因素
      • 對抗生素的擔憂
    • 機會
      • 不斷推出技術先進的產品
      • 智慧創傷護理與數位健康的出現
    • 任務
      • 嚴格的核准流程
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章局部傷口護理藥物市場：依產品

  • 奶油
  • 凝膠
  • 噴

第7章局部傷口護理藥物市場：依應用分類

  • 急性傷口
    • 燒傷
    • 外科性創傷與創傷
  • 慢性傷口
    • 糖尿病足潰瘍
    • 褥瘡
    • 腿部靜脈性潰瘍

第8章局部傷口護理藥物市場：依最終使用者分類

  • 診所
  • 醫院

第9章美洲局部傷口護理市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太局部傷口護理市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的局部傷口護理市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AstraZeneca PLC
  • DUKAL LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Kerecis
  • Medtronic PLC
  • Mylan NV
  • Molnlycke Health Care AB
  • Novartis International AG
  • Pfizer, Inc.
  • Smith & Nephew PLC
  • Swiss-American CDMO
  • Teva Pharmaceutical Industries Ltd
  • Themis Medicare Ltd
  • Vericel Corporation
Product Code: MRR-433C4187C5A4

The Topical Wound Agents Market was valued at USD 2.61 billion in 2023, expected to reach USD 2.89 billion in 2024, and is projected to grow at a CAGR of 10.99%, to USD 5.42 billion by 2030.

Topical wound agents are specialized formulations used for the treatment and management of various types of wounds including abrasions, lacerations, burns, and ulcers. Their scope extends to accelerating healing, preventing infections, and promoting skin regeneration, addressing both acute and chronic wound care needs. The necessity for these agents arises from rising incidences of diabetes-related foot ulcers, an aging global population vulnerable to accidental injuries, and the growing prevalence of surgical procedures. Key applications span hospital settings, home care, and specialized wound clinics, offering products in forms such as creams, ointments, and gels. End-use scope involves healthcare professionals, caregivers, and patients themselves, highlighting a broad range of stakeholder engagement.

KEY MARKET STATISTICS
Base Year [2023] USD 2.61 billion
Estimated Year [2024] USD 2.89 billion
Forecast Year [2030] USD 5.42 billion
CAGR (%) 10.99%

Market insights reveal that technological advancements, such as the integration of smart dressings and bioactive wound agents, are playing influential roles in market growth. Factors driving this growth include increasing healthcare expenditure, heightened awareness regarding advanced wound care, and a rise in cosmetic surgical procedures. However, the market faces challenges including high costs associated with advanced wound care products, stringent regulatory approvals, and variations in reimbursement policies across regions. Opportunities lie in emerging markets where healthcare infrastructure is expanding and unmet medical needs are considerable. Additionally, leveraging digital health solutions for remote wound assessment could tap into telemedicine trends. Recommendations for businesses include a strategic focus on R&D for multifunctional wound care products, fostering collaborations with healthcare providers, and prioritizing market penetration strategies in high-growth regions.

Innovation and research could pivot around developing biodegradable and non-adherent wound dressing materials or investing in enhanced drug delivery systems such as nanoparticles for greater efficiency in wound healing. While exploring the nature of the market, it is crucial to note that it remains competitive and innovation-driven, with significant opportunities still unexplored in personalized medicine. Companies well-positioned to adapt nimbly to these dynamics, continually investing in innovation and aligning with patient and provider demands, are more likely to sustain their growth and competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Topical Wound Agents Market

The Topical Wound Agents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of acute and chronic wounds globally
    • Increasing cases of road accidents and traumatic events
    • Rising government initiatives to increase awareness on wound infections
  • Market Restraints
    • Concerns pertinent to antibiotics
  • Market Opportunities
    • Ongoing introduction of technologically advanced products
    • Emergence of smart wound care and digital health
  • Market Challenges
    • Strict regulatory process for approval

Porter's Five Forces: A Strategic Tool for Navigating the Topical Wound Agents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Topical Wound Agents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Topical Wound Agents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Topical Wound Agents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Topical Wound Agents Market

A detailed market share analysis in the Topical Wound Agents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Topical Wound Agents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Topical Wound Agents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Topical Wound Agents Market

A strategic analysis of the Topical Wound Agents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Topical Wound Agents Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, DUKAL LLC, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Kerecis, Medtronic PLC, Mylan N.V., Molnlycke Health Care AB, Novartis International AG, Pfizer, Inc., Smith & Nephew PLC, Swiss-American CDMO, Teva Pharmaceutical Industries Ltd, Themis Medicare Ltd, and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Topical Wound Agents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cream, Gel, and Spray.
  • Based on Application, market is studied across Acute Wound and Chronic Wound. The Acute Wound is further studied across Burn and Surgical & Traumatic Wound. The Chronic Wound is further studied across Diabetic Foot Ulcer, Pressure Ulcer, and Venous Leg Ulcer.
  • Based on End User, market is studied across Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of acute and chronic wounds globally
      • 5.1.1.2. Increasing cases of road accidents and traumatic events
      • 5.1.1.3. Rising government initiatives to increase awareness on wound infections
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns pertinent to antibiotics
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing introduction of technologically advanced products
      • 5.1.3.2. Emergence of smart wound care and digital health
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory process for approval
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Topical Wound Agents Market, by Product

  • 6.1. Introduction
  • 6.2. Cream
  • 6.3. Gel
  • 6.4. Spray

7. Topical Wound Agents Market, by Application

  • 7.1. Introduction
  • 7.2. Acute Wound
    • 7.2.1. Burn
    • 7.2.2. Surgical & Traumatic Wound
  • 7.3. Chronic Wound
    • 7.3.1. Diabetic Foot Ulcer
    • 7.3.2. Pressure Ulcer
    • 7.3.3. Venous Leg Ulcer

8. Topical Wound Agents Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Topical Wound Agents Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Topical Wound Agents Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Topical Wound Agents Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AstraZeneca PLC
  • 2. DUKAL LLC
  • 3. Integra LifeSciences Corporation
  • 4. Johnson & Johnson Services, Inc.
  • 5. Kerecis
  • 6. Medtronic PLC
  • 7. Mylan N.V.
  • 8. Molnlycke Health Care AB
  • 9. Novartis International AG
  • 10. Pfizer, Inc.
  • 11. Smith & Nephew PLC
  • 12. Swiss-American CDMO
  • 13. Teva Pharmaceutical Industries Ltd
  • 14. Themis Medicare Ltd
  • 15. Vericel Corporation

LIST OF FIGURES

  • FIGURE 1. TOPICAL WOUND AGENTS MARKET RESEARCH PROCESS
  • FIGURE 2. TOPICAL WOUND AGENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TOPICAL WOUND AGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TOPICAL WOUND AGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TOPICAL WOUND AGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TOPICAL WOUND AGENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY BURN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY SURGICAL & TRAUMATIC WOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY DIABETIC FOOT ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRESSURE ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY VENOUS LEG ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. TOPICAL WOUND AGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. TOPICAL WOUND AGENTS MARKET, FPNV POSITIONING MATRIX, 2023